有危险
发表于 2025-3-30 10:04:53
Techno-Economic and Environmental Analysis of a Hybrid Renewable Energy System: Al Qurayyat City, KSAduce rural electrification and global warming problems. This paper aims to provide a techno-economic feasibility and environmental analysis of a HRES to be designed for meeting a daily load requirement of 389.4 kWh/day with a peak load of 82.71 kW, represented by the energy demand of thirty houses l
要控制
发表于 2025-3-30 15:11:46
2366-259X he readers easy to understand the concepts.Covers special chThis book contains diverse topics relevant to earthquake engineering and technology. The chapters are of interest to readers from various disciplines, as the different chapters discuss popular topics on earthquake engineering and allied dis
right-atrium
发表于 2025-3-30 17:40:33
http://reply.papertrans.cn/63/6261/626091/626091_53.png
SUGAR
发表于 2025-3-30 21:09:37
http://reply.papertrans.cn/63/6261/626091/626091_54.png
颠簸地移动
发表于 2025-3-31 01:34:34
http://reply.papertrans.cn/63/6261/626091/626091_55.png
Lacunar-Stroke
发表于 2025-3-31 05:48:48
Phanourios Tamamis,Emmanouil Kasotakis,Georgios Archontis,Anna Mitrakipport the mediation hypothesis and provide evidence that equilibrium in the proportion of franchised and company units is related to a high level of mutual learning, thereby positively influencing the network climate for innovation. Overall, this study contributes to the franchise literature by expl
恶意
发表于 2025-3-31 12:37:04
http://reply.papertrans.cn/63/6261/626091/626091_57.png
Cantankerous
发表于 2025-3-31 15:19:37
http://reply.papertrans.cn/63/6261/626091/626091_58.png
曲解
发表于 2025-3-31 21:07:15
Die Nothwendigkeit einer neuen Parteibildung Zivilgesellschaft war und ist die Eurozonen-Krise Chance und Herausforderung zugleich. Die Beiträge dieses Sammelbandes blicken auf die Rolle der Zivilgesellschaft in der sich ändernden, politischen und gesellschaftlichen Realität der Eurozone. Ziel ist es ein breites Spektrum zivilgesellschaftlich
mitral-valve
发表于 2025-3-31 23:59:01
https://doi.org/10.1007/3-7643-7381-4HIV; Malaria; Tropical Disease; clinical trial; developing countries; diseases; research; tuberculosis; vacc